“…EDN1 [ 50 , 51 ], TYMP [ 52 ], PROCR [ 53 ], F2R [ 35 , 53 ], TGFB1 [ 54 ], BCL2L1 [ 55 ], MMP1 [ 56 ], KDR [ 57 ], SPHK1 [ 58 ], TNFSF10 [ 59 ]) (Tables 2 and 5 ). Finally, pMSCs reduced glucose-treated endothelial cell expression of genes that induce their apoptosis ( FASLG [ 60 ]), injury ( ENG [ 48 ], CX3CL1 [ 61 ], F3 [ 62 ], THBD [ 62 ], AGTR1 [ 63 ]), and inflammation ( IL3 [ 64 ], ALOX5 [ 65 ], FLT1 [ 66 ]) (Tables 2 and 5 ). These data further support pMSCs having a beneficial effect on multiple endothelial cell functions in the presence of glucose.…”